Overview

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
With new strategies and drugs available, many different regimens exist for the treatment of HIV. The purpose of this study is to compare three different anti-HIV drug regimens as first-time treatments for HIV infection.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Efavirenz
Lamivudine
Lopinavir
Ritonavir
Stavudine
Tenofovir
Zidovudine